Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Key words COVID-19 general dermatology medical dermatology Moderna reaction vaccine Introduction Out of 15,185 participants in the phase III Coronavirus Efficacy (COVE) trials who received at least one dose of the Moderna vaccine, 228 (1.5%) reported hypersensitivity adverse events, including injection site rash and urticaria.
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
